<DOC>
	<DOCNO>NCT00263263</DOCNO>
	<brief_summary>Context : Sirolimus-eluting-stents improve benefit percutaneous intervention native coronary artery reduce occurrence restenosis repeat revascularization , however saphenous vein graft always exclude form randomize trial . Objective : To evaluate angiographic clinical impact sirolimus-eluting-stents respect bare-metal-stents degenerate vein graft . Design : Double-blind randomized control non-industry-sponsored trial . Setting : A single-center tertiary-care referral hospital . Patients : All patient randomly allocate sirolimus-eluting-stent implantation correspond bare-metal-stent . All patient follow clinically repeat angiographic follow-up perform 6-months . Main outcome measure : Primary end-point 6-months angiographic in-stent late loss . Secondary end-points include : binary angiographic in-stent in-segment restenosis , intravascular-ultrasound-measured neo-intimal hyperplasia volume clinical event ( death , myocardial infarction , target-lesion target-vessel revascularization ) .</brief_summary>
	<brief_title>RRISC Study : Reduction Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent .</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>18 85 yearsold clear sign and/or symptom stable unstable angina document silent ischemia one denovo target lesion ( &gt; 50 % diameter stenosis visual estimate ) localize one diseased SVG reference vessel diameter ( RVD ) include 2.5 4.0 mm ( visual estimate ) sign informed consent . Myocardial Infarction within previous 7 day document leave ventricular ejection fraction &lt; 25 % impaired renal function ( creatinine &gt; 3.0 mg/dl ) time treatment outflow obstruction graft due distal anastomotic stenosis totally occlude Saphenous Vein Graft brachytherapy treatment index vessel enrollment life expectancy le 12 month know allergy aspirin , clopidogrel bisulfate , heparin , stainless steel , contrast agent sirolimus hemorrhagic diatheses recent positive pregnancy test , breastfeeding , possibility future pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>